Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor
Clinical trial NCT02471716 · COMPLETED
Trial details
- NCT number
- NCT02471716
- Sponsor
- Five Prime Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2020-04-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.